Wednesday, May 01, 2019 12:33:26 PM
GlobeNewswire•May 1, 2019
NEW YORK, NY, May 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities and equity investments, today announced the execution of a Distribution Agreement (the “Agreement”) with a New Jersey based firm with extensive relationships throughout the Northeast region of the USA (“Northeast USA”) and Asia. This is the third distinct major Distribution agreement that the Company has entered into during April of 2019. The thrust of this agreement is to accelerate the market penetration of Tauri-GumTM throughout the Northeast USA as well as Asia. The Company has already received multiple Purchase Orders emanating from this Agreement and has also commenced discussions for a major China based E-Commerce opportunity.
In other news, the Company is pleased to confirm that it has fully paid for the entirety of its 4 Tauri-GumTM production runs; totaling 35,000 Mint flavor blister packs (3,500 Mint flavor retail boxes). Separately, the Company continues to fund its Research & Development initiatives and believes that product innovation is crucial to its long-term success.
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (TAUG) is a revenue generating Company that operates through the development, distribution, and licensing of proprietary products as well as the evaluation of potential acquisition opportunities. One such opportunity on which the Company has acted, involves the Company having entered into the cannabidiol (or “CBD”) infused chewing gum product business, as more fully described above and in prior press releases. This CBD infused chewing gum product has been branded under the following name: Tauri-GumTM. See also our periodic reports filed by us with the SEC for a more complete description of our business and material agreements that we have entered into. Further, the Company continues to identify and evaluate additional potential opportunities to generate revenue, as well as shareholder value, and leverage its resources and expertise to build a diversified and sustainable business model. Please visit our corporate website at www.tauriga.com.
In addition, on March 11, 2019, the Company announced the official launch of its E-Commerce site - as part of its Tauri-GumTM commercialization strategy. This site can be accessed by visiting the following URL address: www.taurigum.com
Buy OVERSOLD, sell OVERBOUGHT...Deep Pockets, so when I begin buying, watch out above! TECHNICAL and FUNDAMENTAL trader..
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM